3 - Supply list.docx

This is a supply list document for a microbiology analyzer and reagent procurement by the Navajo Area Indian Health Service, Chinle Comprehensive Health Care Facility. The list specifies quantities and part numbers for various Cepheid diagnostic kits and supplies, including molecular testing kits for BCR-ABL, MRSA, MPOX, hepatitis C, Ebola, NPM1 mutation, and PML-RARA, as well as collection devices such as eSwabs, nasopharyngeal swabs, and urine collection kits. Additional items include respiratory panels (Xpert Flu/RSV, Xpert CoV-2/Flu/RSV), sexually transmitted infection kits (Xpert CT/NG, Xpert GBS), and tuberculosis testing supplies (Xpert MTB/RIF, Xpert Carba-R-10), with quantities ranging from single units to over 5,000 units for high-volume tests like Xpert CT/NG.

This procurement is structured as a sole-source, non-competitive purchase order to Cepheid under Special Notice IHS1529039, with performance spanning one one-year base period plus four one-year option periods. The NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing) with a small business size standard of 1,250 employees. Following an unsuccessful Sources Sought Notice issued April 7-21, 2026, the Government determined Cepheid is the only source capable of providing the required microbiology analyzer and reagent supplies without service interruption to patient care. Any responses challenging the sole-source justification must be submitted by September 17, 2026, at 5:00 p.m. MST, after which the contract will be issued. The Government retains discretion to reject the sole-source determination if compelling evidence of competition is presented.